BJP Mental Health Guidelines from NICE
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

Journal of Mental Science (1961) 107: 583-589. doi: 10.1192/bjp.107.448.583
© 1961 The Royal College of Psychiatrists
This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jenner, F. A.
Right arrow Articles by Parkin, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jenner, F. A.
Right arrow Articles by Parkin, D.

A Controlled Comparison of Methaminodiazepoxide (Chlordiazepoxide, "Librium") and Amylobarbitone in the Treatment of Anxiety in Neurotic Patients

F. A. Jenner, M.B., Ch.B., Ph.D., D.P.M., Lecturer in Psychiatry, R. J. Kerry, L.R.C.P., M.R.C.S., D.P.M., Senior Registrar and D. Parkin, M.B., Ch.B., D.P.M., Registrar

Department of Psychiatry, The United Sheffield Hospitals and the University of Sheffield

ABSTRACT

A controlled trial of methaminodiazepoxide 20 mg. three times a day against amylobarbitone 60 mg. three times a day has been performed in neurotic patients complaining of anxiety. The results show highly significantly that patients usually prefer methaminodiazepoxide. Other factors are also discussed.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1961 The Royal College of Psychiatrists.